Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
lovastatin + berberine
- Development stage
- Preclinical
- Lead developer
- Mogon Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Red Rise (lovastatin + berberine) is a preclinical-stage oral combination product being developed by Mogon Pharmaceuticals, a Swiss pharmaceutical company specializing in drug delivery systems. The formulation combines monacolin K (also referred to as monacoline or mevacolin, and chemically identical to lovastatin), a statin-class HMG-CoA reductase inhibitor derived from red yeast rice, with berberine, a plant-derived alkaloid with antidiabetic and lipid-modulating properties. The product is designed as an improved or modified oral-release tablet intended for cholesterol lowering (hypercholesterolemia), leveraging a synergistic effect between the HMG-CoA reductase inhibition of the statin component and the metabolic regulatory mechanisms of berberine, which include AMPK activation and PCSK9 downregulation.
- Brand names
- Red Rise
- Other names
- monacoline mevacolin + berberinemonacolin K + berberineMonacolineMevacolinBerberine
02
Targets
CSF1R (Macrophage colony-stimulating factor receptor)HMGCR (3-hydroxy-3-methylglutaryl-coenzyme A reductase)KCNMA1 (Calcium-activated potassium channel subfamily M alpha member 1)KIT (c-KIT proto-oncogene receptor tyrosine kinase)LDLR (Low-density lipoprotein receptor)PCSK9 (Proprotein convertase subtilisin/kexin type 9)PIK3CD (Phosphatidylinositol 3-kinase delta)ROCK2 (Rho-associated coiled-coil containing protein kinase 2)AMPK (Adenosine monophosphate–activated protein kinase)
Beyond the preview
Go deeper on lovastatin + berberine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on lovastatin + berberine.